MTOR and ovarian cancer: In this research we successfully proved that ITGB2 expression could promote glycolytic transformation in mitochondria through activating PI3K-AKT-mTOR signal pathway, thereby preserving mitochondrial stability and fostering malignant characteristics in ovarian cancer cells.